2,354 material Form 8-K filings that 2,004 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On October 28, 2026, Stewards, Inc. sold an unsecured convertible promissory note with a principal amount of $6,050,000 to Crom Structured Opportunities Fund I, LP for $5,500,000. The note matures in 12 months, and the investor can convert it into common stock from January 31, 2027, at 90% of the lowest daily VWAP over the prior five trading days, which could add substantial dilution for shareholders. The company plans to use about $4,937,000 in net proceeds to fund its proposed acquisition of PIXL, LLC, though no definitive agreement has been signed.
Note: $6,050,000 principal, $5,500,000 purchase price, 10% original issue discount, due in 12 months
Conversion from January 31, 2027 at 90% of the lowest five-day VWAP, with a full-ratchet anti-dilution adjustment
Share reserve of at least 7,000,000 shares; issuance above 45,309,740 shares (19.99%) requires stockholder approval, given by majority holders by written consent on October 28, 2026
Placement agent E.F. Hutton & Co. received a $440,000 cash fee and warrants for 121,109 shares at $2.498
Wabtec priced a $500 million offering of 5.900% Senior Notes due 2037 on November 2, 2026. The company plans to use the proceeds, together with borrowings under its revolving credit facilities, short-term facilities and/or commercial paper, to repay its 3.450% Senior Notes due November 15, 2026. The sale is expected to close on November 4, 2026.
Offering: $500 million aggregate principal of 5.900% Senior Notes due February 25, 2037, priced November 2, 2026
Use of proceeds: repay the 3.450% Senior Notes due 2026 at maturity on November 15, 2026, alongside other borrowings
Expected closing: November 4, 2026, subject to customary closing conditions
Joint book-running managers: BofA Securities, Citigroup Global Markets, PNC Capital Markets and TD Securities
AH Realty Trust's operating partnership entered new credit agreements on October 28, 2026, providing a $150.0 million revolving credit facility and three term loans totaling $500.0 million, which replace four prior loan facilities. The filing also describes a separate $121.8 million secured term loan for subsidiaries that own the Constellation Tower property, with the financing terms and covenants taking effect for shareholders as a refinancing of existing debt.
On October 28, 2026, the operating partnership signed a Fourth Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent, including a $150.0 million revolver maturing October 28, 2031, a $200.0 million 4-year
A separate $100.0 million 7-year term loan maturing October 28, 2033 was arranged with Toronto Dominion (Texas) LLC, with an accordion feature allowing increases up to $250.0 million maximum outstanding.
The new loans replace a $355.0 million revolver, a $350.0 million term loan, a $135.0 million term loan with Manufacturers and Traders Trust Company, and a $95.0 million term loan with Toronto Dominion (Texas) LLC.
Constellation subsidiaries entered a $121.8 million term loan maturing October 28, 2029 with PNC Bank, N.A., priced at Daily Simple SOFR plus 1.80% and secured by the Constellation Tower property.
Acadia Realty Trust filed a new automatic shelf registration on Form S-3 to replace its 2023 shelf, which expires November 7, 2026, and amended its at-the-market equity offering program. The amendment adds Citizens JMP Securities as an additional sales agent and forward purchaser, and about $199 million remains available under the program. The filing describes routine capital-raising housekeeping, and it signals that the company can issue new common shares under the program, which would dilute existing holders if used.
New automatic shelf registration on Form S-3 filed November 3, 2026, replacing the 2023 shelf that expires November 7, 2026
Amendment No. 1 covers common shares with an aggregate sale price of up to $500 million under the at-the-market program
As of the amendment date, up to $199,062,233.91 in common shares remained available for issuance under the program
Citizens JMP Securities, LLC added as an additional sales agent and forward purchaser
On November 3, 2026, Procter & Gamble closed an underwritten public offering of four series of euro-denominated notes under its existing Form S-3 shelf registration, totaling €3.25 billion in principal. The notes mature between 2030 and 2046 and carry coupons from 3.750% to 4.625%, so the offering adds long-term debt to the company's balance sheet.
Four tranches: €750 million due November 3, 2030 at 3.750%; €1.0 billion due November 3, 2034 at 4.100%; €750 million due November 3, 2038 at 4.250%; €750 million due November 3, 2046 at 4.625%
Offering closed on November 3, 2026, under Registration No. 333-299472
Legal opinions filed as Exhibits 5(a) and 5(b); the filing does not state the use of proceeds
Enova International furnished a Form 8-K disclosing a proposed private offering of $500,251,000 in Series 2026-2 fixed rate asset-backed notes by subsidiary OnDeck Asset Securitization IV, LLC, backed by small business loans from OnDeck. The filing also furnishes supplemental historical loan performance data made available to potential note purchasers, and the notes will not be obligations of or guaranteed by Enova or OnDeck, so shareholders' direct exposure is limited to the terms and completion of the offering.
Proposed offering of $500,251,000 aggregate principal amount of Series 2026-2 Fixed Rate Asset-Backed Notes by OnDeck Asset Securitization IV, LLC
Issuer is sole obligor; notes are not obligations of, or guaranteed by, Enova or OnDeck
Notes offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S; terms and timing depend on market conditions
Supplemental data was made available to potential purchasers on November 3, 2026, covering term loans and lines of credit with original terms of 24 months or less and minimum loan yields of at least 10%
On November 3, 2026, H2O America issued and sold 7,475,000 corporate units under an October 29, 2026 underwriting agreement with Wells Fargo Securities and J.P. Morgan Securities as representatives. Each unit combines a stock purchase contract requiring the holder to buy common stock by November 1, 2029 with a 1/20 interest in $1,000 of 5.300% remarketable senior notes due 2031, so the sale may lead to new common shares being issued.
7,475,000 corporate units sold, including 975,000 units from the full exercise of the underwriters' over-allotment option.
Each unit has a $50 stated amount; the stock purchase contract is due no later than November 1, 2029, for $50 in cash per contract.
Total annual distributions are 7.750% of the stated amount: 2.450% in contract adjustment payments and 5.300% in note interest.
The senior notes will be remarketed before the stock purchase contract settlement date, under a remarketing agreement not yet signed as of the filing.
Blue Acquisition Corp, a Cayman Islands blank-check company, issued an unsecured, non-interest-bearing promissory note of up to $50,000 to director Dario Dino Ferrari to fund working capital. The note is repayable only upon completion of its proposed business combination with Blockfusion USA, Inc. or on liquidation, and repayment outside the trust account is limited to any funds remaining there, which is a modest financing step with limited dilution-free funding for shareholders.
Unsecured promissory note issued November 3, 2026, for up to $50,000 to director Dario Dino Ferrari
Note bears no interest; principal due on the earlier of the Blockfusion business combination or liquidation
Payee waives claims against the trust account; repayment otherwise limited to funds outside the trust, if any
Sands China, a majority-owned subsidiary of Las Vegas Sands, completed a $1.0 billion private offering of senior unsecured notes on November 3, 2026. The company said it intends to use the proceeds and cash on hand to redeem its $700 million 2.300% notes due 2027, repay its 2024 SCL Revolving Facility balance, and for general corporate purposes. The filing does not state a direct effect on Las Vegas Sands' reported results, but the new debt is an obligation of its Hong Kong-listed subsidiary.
$700 million of 6.400% Senior Notes due 2032 and $300 million of 6.700% Senior Notes due 2033, totaling $1.0 billion
Notes mature January 8, 2032 and November 8, 2033; both are listed on The Stock Exchange of Hong Kong
Proceeds, with cash on hand, intended to redeem in full the $700 million 2.300% notes due 2027 and repay the 2024 SCL Revolving Facility balance
Notes are unguaranteed by Sands China's subsidiaries and structurally subordinated to their liabilities
Radian Group's UK subsidiary ICML amended and restated its letter of credit facility with a syndicate of banks led by Barclays, raising lender commitments from $620 million to $880 million. Radian Group is now guarantor of ICML's obligations, replacing Inigo Limited, and the facility supports ICML's Lloyd's underwriting for the 2027 year of account and prior open years. The facility carries financial covenants and cross-default risk to Radian Group's revolving credit facility and senior notes.
Lender commitments increased from $620 million to $880 million, effective October 29, 2026
Radian Group added as guarantor; Inigo Limited removed as guarantor
Letters of credit have a minimum term of four years and expire no later than December 31, 2030
Covenants include minimum consolidated net worth and maximum Debt-to-Total Capitalization; a default could trigger defaults under Radian Group's RCF and senior notes
Liminatus Pharma agreed on November 2, 2026 to sell 260,001 common shares at $2.50 each in a private placement to a non-U.S. investor, raising gross proceeds of $650,002.50. The company plans to use the proceeds for working capital and general corporate purposes, with closing expected on or about November 20, 2026. The company also agreed to file a resale registration statement within 60 days of closing, which could add shares that may be sold into the market later.
Shares: 260,001 common shares at $2.50 per share
Gross proceeds: $650,002.50, for working capital and general corporate purposes
Expected closing: on or about November 20, 2026
Company must file a resale registration statement with the SEC within 60 days of closing
Bunge Global SA and certain subsidiaries amended their existing trade receivables securitization program on October 30, 2026, extending its termination date by 364 days to December 13, 2027. The filing says other key terms were substantially unchanged and does not disclose a dollar size for the program.
Amendment dated October 30, 2026 extends the program's termination date by 364 days to December 13, 2027.
Purchasers permitted a merger of one Dutch originator into another Dutch subsidiary, which survives as a Dutch originator.
Bunge's recourse is limited to its first loss position as subordinated lender, apart from repurchase obligations for ineligible receivables.
BWX Technologies entered into an amendment to its existing credit agreement with Wells Fargo as administrative agent and other lenders. The amendment extends the maturity of the $1.25 billion senior secured revolving credit facility by one year to November 10, 2031, and changes the interest coverage covenant and pricing terms.
Maturity of the $1.25 billion senior secured revolving credit facility extended one year to November 10, 2031
Minimum interest coverage ratio no longer applies if no default exists and the company obtains investment grade ratings (stable outlook or better) from at least two designated rating agencies
Pricing grid set to the lower of the existing leverage-based grid or a grid tied to the company's corporate ratings
On November 2, 2026, Ocean Power Technologies entered a Securities Purchase Agreement with Vanquish Funding Group and issued a 12% promissory note with a principal of $373,750 for a purchase price of $325,000, with up to $2,875,000 in additional tranches possible over the next twelve months, subject to further agreement. The note's conversion feature applies only after an Event of Default, at 75% of the lowest closing bid price over the prior ten trading days, which could lead to dilution for shareholders.
Note principal of $373,750 issued for a $325,000 purchase price, including a $48,750 original issue discount; matures October 30, 2027
Up to $2,875,000 in additional financing tranches possible over the next twelve months, subject to further agreement
Conversion into common stock is possible only after an Event of Default and not before 180 days after issuance, at 75% of the lowest closing bid price over the prior ten trading days
On default, the company must pay 150% of outstanding amounts plus collection costs; the company is responsible for $7,000 of Vanquish's fees
Fathom Holdings signed a Third Omnibus Amendment to its Senior Secured Convertible Promissory Notes with the holders on November 2, 2026. The amendment extends the Maturity Date from November 1 to November 30, 2026, defers accrued interest to the new maturity date, and adds weekly extension fees of 0.5% of outstanding principal. Because the deferred interest and fees add to the amount owed, shareholders face a larger payment due at maturity. The chairman of the board, Scott Flanders, is one of the holders, and the independent directors approved the transaction.
Maturity Date extended from November 1, 2026 to November 30, 2026.
All accrued and unpaid interest is deferred, and the 18% per annum rate continues to apply to outstanding principal.
Weekly extension fee of 0.5% of outstanding principal is due on November 9, 16, 23 and 30, 2026, if principal remains outstanding.
Chairman Scott Flanders is a Holder of one of the Notes; a majority of independent, disinterested directors approved the transaction.
Reed's, Inc. agreed on October 28, 2026 to sell 17,421,602 shares of common stock to D&D Source of Life Holding, Ltd., its majority stockholder, at $0.574 per share, for gross proceeds of approximately $10.0 million, expected to close on or about November 6, 2026. The filing says the proceeds satisfy a minimum cash equity contribution requirement under the company's senior secured loan amendment, and the company intends to use the funds for working capital and general corporate purposes.
Shares priced at $0.574 each; 17,421,602 shares; gross proceeds of approximately $10.0 million
Expected closing on or about November 6, 2026, the same deadline set by the loan amendment
Company must file a resale registration statement within 15 days after closing; target effectiveness within 70 days (90 if SEC conducts a full review)
Shares sold privately under Section 4(a)(2) and Rule 506(b), so they are unregistered
On November 3, 2026, CMS Energy issued and sold $1 billion of 6.800% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057 under a shelf registration. The company plans to use the net proceeds to repay its $275 million 2.95% Senior Notes due February 2027 and its $350 million 3.45% Senior Notes due August 2027, and for general corporate purposes. The filing mainly adds offering documents as exhibits to the registration statement.
$1,000,000,000 principal of 6.800% junior subordinated notes due 2057 issued November 3, 2026, under shelf registration No. 333-293382
Proceeds earmarked to repay $275 million 2.95% senior notes due February 2027 and $350 million 3.45% senior notes due August 2027, plus general corporate purposes
Estimated offering expenses total $1,800,000, including $1,550,350 in rating agency fees
Underwriters named include Deutsche Bank Securities, J.P. Morgan Securities, Mizuho Securities, Morgan Stanley, MUFG Securities Americas and Wells Fargo Securities
Kairos Pharma amended its equity line of credit purchase agreement with Helena Global Investment Opportunities I Ltd. three times in 2026, changing the purchase price, the pricing period and the period during which the company can use the facility. The company also furnished materials for a November 3, 2026 conference presentation on interim efficacy data for ENV-105. The filing does not state the number of shares or the proceeds involved, but the amendments change the terms under which shares can be sold to Helena, which matters to shareholders.
February 4, 2026: purchase price set at 97% of the average daily VWAP during the Pricing Period.
October 26, 2026: Pricing Period shortened from three Trading Days to one Trading Day.
October 29, 2026: option to use the equity line extended one year to December 31, 2028.
November 3, 2026: President and Chief Scientific Officer Neil Bhowmick presents interim ENV-105 data; median progression-free survival was 17.7 months with the combination versus 2 months with apalutamide alone (P=0.0008).
Bread Financial Holdings issued and sold 5,000,000 depositary shares on November 3, 2026, each representing a 1/40th interest in a share of its 9.375% Series C Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, which has a $1,000 liquidation preference per share. The Series C terms restrict dividends on junior stock and repurchases of parity or junior stock if the company does not declare and pay or set aside dividends on the Series C for the prior dividend period. Holders of the depositary shares receive proportional dividend, voting, redemption and liquidation rights.
5,000,000 depositary shares issued and sold on November 3, 2026, each a 1/40th interest in a Series C preferred share
Series C carries a 9.375% fixed rate reset, non-cumulative perpetual preferred stock with a $1,000 liquidation preference per share
Underwriters hold a 30-day option, from October 27, 2026, to buy up to 750,000 additional depositary shares
Certificate of Designations filed with Delaware on November 2, 2026 and effective November 3, 2026
On October 29, 2026, Weis Markets and its subsidiaries amended their unsecured revolving credit agreement with Wells Fargo Bank. The facility provides a $30 million principal commitment, with an additional $70 million of discretionary availability, and matures on October 1, 2030. The filing says the other terms are consistent with the prior agreement and does not state any amount borrowed under the facility.
Unsecured revolving facility: $30 million aggregate principal commitment plus $70 million discretionary availability.
Maturity date is October 1, 2030; no principal payments are due before maturity.
Loans bear interest at 1.00% above Daily Simple SOFR, and an unused fee of 0.25% applies.
Company must maintain minimum EBITDA of $175 million, tested quarterly on a trailing twelve-month basis.
Indivior's 8-K says a special dividend declared by the board on September 16, 2026 triggered an increase in the conversion rate on its 0.625% Convertible Senior Notes due 2031, from 24.0033 to 30.9355 common shares per $1,000 principal, a conversion price of approximately $32.33 per share. The filing is signed by Supernus, Inc. (f/k/a Indivior Pharmaceuticals, Inc.), and it states that no bondholders converted their notes for common stock.
Special dividend declared by the board on September 16, 2026 triggered the adjustment.
Conversion rate per $1,000 principal increased from 24.0033 to 30.9355 common shares.
Implied conversion price is approximately $32.33 per share.
No bondholders converted their notes for common stock.
Geospace Technologies entered into a three-year, $25 million revolving credit facility with Amerisource Funding on October 29, 2026, and used it to repay and terminate its existing Woodforest credit agreement, which had a $7.5 million outstanding balance. The new facility carries prime plus 3.5% interest, is secured by substantially all borrower assets, and includes a $65.0 million minimum tangible net worth covenant, so shareholders should note the tighter terms and the lender's default provisions.
New Amerisource revolver: $25 million maximum availability, subject to a borrowing base, three-year term
Interest at prime rate plus 3.5% per annum; default rate of 18% per annum if obligations are accelerated
Minimum tangible net worth covenant of $65.0 million; 1.00% annual commitment fee and 0.25% non-usage fee
Woodforest credit agreement, which had a $7.5 million outstanding balance, was repaid and terminated, with no material early termination penalties reported
On November 2, 2026, AEON Biopharma amended its two-year milestone warrants to reduce their exercise price from about $0.32 to $0.20 per share, with holders of at least 67% of the underlying shares agreeing. Certain holders have agreed to exercise at the lower price, and the company expects about $6.2 million in gross proceeds. The amendment applies to all outstanding warrants, which expire on November 16, 2026, after the FDA's September 30 feedback triggered accelerated expiration.
Exercise price cut from $0.3221 to $0.20 per common share, effective November 2, 2026
Company expects approximately $6.2 million in gross proceeds from warrant exercises
Amendment applies to all outstanding Two-Year Warrants; share count and expiration date unchanged
Warrants expire November 16, 2026; 71,517,020 common shares were outstanding as of October 30, 2026
Peraso Inc. completed a private placement to Nant Capital, LLC on October 28, 2026, issuing 3,271,355 shares, pre-funded warrants and common warrants for aggregate gross proceeds of approximately $10.0 million before offering expenses. The filing says the company will use the proceeds for working capital and general corporate purposes, and the warrants could add up to 36,458,481 shares of common stock, which would dilute existing shareholders. The company has also agreed to register the resale of these shares, and the filing lists going concern and Nasdaq listing compliance among its risk factors.
Closing date was October 28, 2026; the Purchase Agreement was signed October 26, 2026.
Shares were sold at $0.5034 each, with pre-funded warrants priced at $0.5024 each, both including a common warrant.
Common warrants have an exercise price of $0.3784 per share and expire October 28, 2028.
A resale registration statement is due by November 27, 2026, with liquidated damages of 1.0% per month, up to 5.0%, if deadlines are missed.
Our Bond, Inc. (OBAI) converted its senior secured loan from Eastward Fund Management and fees owed to Maxim Group into Series G Preferred Stock, and exchanged older Series C and D preferred stock for Series G with Ascent Partners. On November 3, 2026, it also agreed to sell up to $10 million of common stock to an accredited investor, with $250,000 issued at the initial closing. The filing describes dilution-related terms, including conversion price adjustments, resale registration obligations, and leak-out limits on the holders' stock sales, which matter to shareholders because the share count could grow.
Eastward loan obligations of $7,878,149.32 converted into 787,815 Series G Preferred shares; Eastward's Series B-1 Warrants were retired.
Maxim fees of $803,940.82 converted into Series G Preferred shares; Ascent exchanged 52,500 Series C and 525,451 Series D preferred shares for 577,948 Series G shares.
November 3, 2026 private offering: up to $10,000,000 of common stock at $2.75 per share; initial closing issued 90,909 shares for $250,000.
Series G conversion price is $2.0265 per common share, with dividends at 10% annually, rising to 24% after a triggering event.
Cheniere Energy agreed on November 2, 2026 to sell $1.2 billion of 5.800% senior notes due 2037 through Morgan Stanley & Co. LLC as representative of the initial purchasers, and priced the offering that day. The company says proceeds may be used for general corporate purposes, including repaying or refinancing existing debt such as its subsidiary's 5.125% notes due 2027, plus capital expenditures and working capital, which would affect the company's debt profile for shareholders.
Principal amount of $1.2 billion, issued at 99.313% of par, with interest at 5.800% per year.
Notes mature March 15, 2037; closing is expected on November 17, 2026.
Offering is a private sale to qualified institutional buyers under Rule 144A and to persons outside the United States under Regulation S.
Proceeds may repay, refinance or redeem existing debt, including subsidiary Cheniere Corpus Christi Holdings' 5.125% Senior Secured Notes due 2027.
Xcel Energy priced an upsized private offering of $2.2 billion in 2.625% convertible senior notes due December 15, 2027, with an option for up to $300 million more. The company expects net proceeds of about $2.18 billion, to be used mainly to repay short-term borrowings, and expects the sale to close on November 5, 2026. Conversion would be at an initial price of about $87.26 per share, and the company may settle the principal in cash, but share issuance is possible for amounts above principal.
Pricing of $2,200,000,000 of 2.625% convertible senior notes due December 15, 2027, upsized from $2,000,000,000
Initial purchasers have a 13-day option for up to an additional $300,000,000 of notes
Expected net proceeds of about $2,178,500,000, or $2,476,250,000 if the option is fully exercised
Initial conversion price of about $87.26 per share, a 10.0% premium to the last reported sale price on November 2, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.